Norwich Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NORWICH, and what generic and branded alternatives to NORWICH drugs are available?
NORWICH has two approved drugs.
There is one tentative approval on NORWICH drugs.
Summary for Norwich
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Norwich
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-003 | Apr 21, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-002 | Apr 21, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Norwich | LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | CAPSULE;ORAL | 214547-006 | Aug 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-001 | Apr 21, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Norwich | LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | CAPSULE;ORAL | 214547-002 | Aug 25, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Norwich
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-001 | Apr 21, 1993 | 4,892,741 | ⤷ Sign Up |
| Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-002 | Apr 21, 1993 | 5,264,446 | ⤷ Sign Up |
| Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-003 | Apr 21, 1993 | 4,892,741 | ⤷ Sign Up |
| Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-003 | Apr 21, 1993 | 5,264,446 | ⤷ Sign Up |
| Norwich | ADALAT CC | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 020198-002 | Apr 21, 1993 | 4,892,741 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
